Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-566-5 | CAS number: 585-86-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Deviations:
- yes
- Remarks:
- Characterization of test and control substances not documented according to GLP, however, the purity of the materials used was certified by a reputable Supplier.
- GLP compliance:
- yes
Test material
- Reference substance name:
- 4-O-β-D-galactopyranosyl-D-glucitol
- EC Number:
- 209-566-5
- EC Name:
- 4-O-β-D-galactopyranosyl-D-glucitol
- Cas Number:
- 585-86-4
- Molecular formula:
- C12H24O11
- IUPAC Name:
- 4-O-beta-D-galactopyranosyl-D-glucitol
Constituent 1
- Specific details on test material used for the study:
- DETAILS OF TEST MATERIAL
- Purity:100%
- Physical Description: White powdery solid
- pH: 5.1
- Stability: Test substance was expected to be stable for the duration of testing.
- Expiration Date: June 29, 2024
- Test substance was stored at room temperature; Testing was carried out on the test substance as received.
Test animals / tissue source
- Species:
- other: In vitro EpiOcular™ tissues containing stratified human keratinocytes
- Details on test animals or tissues and environmental conditions:
- - Justification of the test method and considerations regarding applicability: Test was performed according to OECD Guideline 492 using EpiOcular™ Eye Irritation Test (EIT). The test system (tissue construct model) was developed by MatTek Corporation and the EpiOcular EIT was validated and approved by regulatory authorities for evaluation of eye irritation potential. The assay allows for hazard identification of irritant substances in accordance with UN GHS and for discrimination between irritants that fall within Category 2 and non-irritants but does not discriminate between non-mandatory subcategories of the UN GHS.
- Description of the cell system used, incl. certificate of authenticity and the mycoplasma status of the cell live: commercially available RhCE tissue constructs
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 50 mg
- Duration of treatment / exposure:
- 6 hours
- Duration of post- treatment incubation (in vitro):
- 18 hours
- Number of animals or in vitro replicates:
- 2
- Details on study design:
- TISSUE CONDITIONING (DAY 0): Prior to performing the test and whenever assay medium was used, it was allowed to come to room temperature. On the day the tissue was used, the plate was allowed to sit at room temperature for at least 15 minutes. Each tissue was inspected closely for air bubbles beneath the tissue and any found encompassing> 50% of the tissue surface were not used. Under sterile conditions each tissue insert was transferred into a well in previously prepared 6-well plates containing 1 mL of pre-warmed assay medium. Any agarose gel adhering to the outer surface of the inserts was blotted on sterile absorbent material before transferring. The tissues were incubated at 37.1°C and 5% CO2 for approximately 60 minutes, followed by a media change and further incubation until the following day (approximately 20 hours).
CHEMICAL EXPOSURE (DAY 1): After conditioning, all tissues were pre-wetted with 20 µL of sterile DPBS applied to the surface of the insert and incubated for 28 minutes at 37.l-37.4°C and 5% CO2 prior to test or control substance application. Tissues were removed from the incubator just prior to exposure. The test substance was allowed to thaw prior to use. Using a pipette, 50 mg of undiluted test substance(s), 50 μL of negative control (NC; deionized water), or positive control (PC; methyl acetate) was applied to the surface of two tissues/substance. Once all tissues were treated, plates were incubated for 6 hours at 37.0°C and 5% CO2. After exposure, the tissues were removed from the incubator and thoroughly rinsed of test and control substances. For each set of 2 tissues, 3 vessels containing at least 100 mL of sterile DPBS were used. The contents were decanted onto absorbent material and the inserts were fully submerged into the
first beaker of DPBS. Inserts were swirled to rinse, filled, and the liquid was decanted back into the beaker a total of 3 times. This was repeated in fresh DPBS two additional times. After the final rinse, the remaining DPBS was decanted onto absorbent material. The tissues inserts treated with solid substance (test substance) were transferred to new 12-well plates containing assay medium/well and allowed to soak submerged for 25 minutes at ambient temperature. After the post-treatment soak, the tissue inserts were removed, decanted, the outside blotted, and transferred to pre-labelled 6-well plates containing 1 mL of assay media/well. Plates were then incubated for approximately 18 hours at 37.0° C and 5% CO2.
MTT VIABILITY TEST: A 1 mg/mL MTT medium solution was prepared by combining 1 mL of the MTT concentrate (thawed) with 4 mL of MIT diluent provided. 300 μl of MTT medium was pipetted into a sufficient number of wells of a pre-labelled 24-well plate. Inserts were removed from the 6-well plates, residual media was blotted as needed and then transferred into the appropriately labelled wells of the 24-well plate. The tissues were incubated in MTT medium (37.0°C, 5% CO2) for approximately 3 hours. The tissue inserts were removed from the MTT medium, the bottoms were blotted on absorbent material, and the inserts were transferred to 6-well plates containing 1 mL of isopropanol in each well. The plate was sealed to prevent evaporation. Samples were extracted at ambient temperature for at least two hours under gentle shaking. After the extraction period was complete, the inserts were removed and discarded, and 1 mL of isopropanol was added to the extractant solution in each well. The solution was mixed in each well and duplicate 200 μL aliquots of each were transferred into a 96-well plate. Isopropanol was used as blanks.
EVALUATION: Optical density (OD) was read in a 96-well plate spectrophotometer using a wavelength of 570 nm without using a reference filter. Blank corrected OD values were calculated by subtracting the OD of the blank wells from the OD of all other measured wells. The mean OD value of each pair of aliquots was then calculated for each tissue including the killed tissue controls. The mean collected OD for treated viable tissues was calculated. The resulting mean OD for the negative control treated tissue corresponds to 100% viability for the assay.
Viability[%]= corrected test article OD+ corrected mean negative control OD x 100
VALIDATION CRITERIA: The results of the study were acceptable if the following criteria were met:
I) The negative control OD is> 0.8 and< 2.5,
2) The mean relative viability of the positive control is < 50% of control viability
3) The difference of viability between the two relating tissues of a single chemical is <20%
STATISTICAL ANALYSIS: Statistical analysis was limited to the calculation of the mean and standard deviation of OD, as well as % viability of the tissue.
Results and discussion
In vitro
Results
- Irritation parameter:
- other: % tissue viability
- Value:
- 94.8
- Negative controls validity:
- valid
- Remarks:
- 100% viability
- Positive controls validity:
- valid
- Remarks:
- 28.3% viability
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- OTHER EFFECTS:
- Visible damage on test system: none reported
DEMONSTRATION OF TECHNICAL PROFICIENCY:
ACCEPTANCE OF RESULTS:
- Acceptance criteria met for negative control: yes; average optical density was 2.020; viability was 100% with SD of 7.54
- Acceptance criteria met for positive control: yes; average optical density was 0.571; viability was 28.3 with SD of 7.5
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test substance was predicted to be a non-irritant (mean viability was 94.8%)
- Executive summary:
The in vitro EpiOcular eye irritation test (EIT) was performed using the EpiOcular tissue construct, which models the cornea epithelium with progressively stratified, but non-cornified cells. The assay measures destruction of the ocular tissue, one component predictive of ocular irritation. The reduction of the viability of tissues exposed to chemicals in comparison to negative control treated tissue was used to predict the ocular irritation potential.
Viable tissue constructs were randomly allocated to three groups of two matrices each; one test substance group, a positive control group, and a negative control group. Methyl acetate and deionized water were used as the positive and negative controls, respectively.
The EpiOcular tissue were conditioned to the assay media prior to exposure to test or control substances. Each substance was applied directly to the surface of duplicate tissue matrices. Treated tissues were exposed to the test or control substance for 30 minutes and rinsed thoroughly with DPBS. Rinsed tissues were incubated for approximately 2 hours, followed by MIT (3-[4,5- dimethylthiazol-2-yl]-2,5-diphenyltctrazolium bromide) exposure for 3 hours. The tissues were then extracted with isopropanol in a refrigerator overnight for approximately 16 hours. The resulting extraction solution from each tissue was sampled and optical density (OD) measured using a spectrophotometer. The relative viability of each treated tissue was calculated based on the mean OD compared to that of the negative control treated tissue.
Average % viability was 94.8, 100.0, and 28.3 for lactitol, negative control (deionized water) and positive control (methyl acetate), respectively. Under the conditions of this study, lactitol is not considered to be an ocular irritant.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.